This remains the best AI chip stock stock to buy, Wolfe says

Wolfe Research reaffirmed its bullish view on AI chip stocks, raising estimates on Nvidia and Broadcom and naming Nvidia its top pick ahead of earnings season. The firm said hyperscaler capex concerns have faded and that agentic AI should keep cloud spending elevated, while noting Nvidia's weaker recent performance versus peers is tied to less clear 2027 revenue visibility. Wolfe reiterated Outperform ratings on Nvidia, Broadcom and Marvell, saying clearer forward guidance could help Nvidia close the gap.

Analysis

The key read-through is that AI capex is transitioning from discretionary pilot spend to infrastructure maintenance spend. Once hyperscalers commit to agentic workflows, compute becomes embedded in product latency, model quality, and developer retention, which makes cuts politically and competitively costly. That shifts the earnings debate from “will they spend?” to “who captures the mix of that spend,” which is why forward visibility matters more than near-term beat/raise optics.

Relative performance is being driven less by fundamentals than by disclosure asymmetry. Names that can credibly map demand into a 2027 revenue bridge deserve a higher multiple, while the leader without that bridge can lag even if absolute demand is stronger. That creates a short-term valuation setup where the stock with the best unit economics can underperform the stock with the cleanest roadmap, especially into earnings when guidance dispersion widens.

The second-order risk is that margin pressure and custom silicon fears may compress breadth in the group even if aggregate AI spend stays elevated. Suppliers with weaker pricing power or less diversified customer bases are more exposed if hyperscalers push harder on terms to offset capex intensity. The longer-dated bull case remains intact, but near-term sentiment could still rotate toward names with clearer backlogs, better mix, and more explicit next-year commentary.

Contrarian takeaway: the market may be underestimating how little optionality hyperscalers actually have once agentic AI becomes a product requirement rather than an experiment. If the spend is structurally unavoidable, then any pullback is likely to show up first as slower growth in adjacent cloud categories, not a real reduction in AI compute demand. That argues for buying weakness in the highest-quality enablers rather than chasing the strongest recent movers.

Key Decisions for Investors

• Long NVDA on earnings weakness, 1-3 month horizon: use any post-print dip to build exposure, targeting a re-rating if management improves 2027 visibility; risk is continued multiple compression if guidance remains opaque.
• Relative value: long NVDA / short AMD into earnings, 4-8 weeks: express the thesis that disclosure and platform breadth matter more than recent share-price momentum; cover if AMD continues to win mindshare on forward visibility.
• Long AVGO vs. MRVL, 2-4 months: AVGO offers better monetization of AI infrastructure with more resilient mix; MRVL remains a cleaner beta beneficiary but with higher execution risk if custom silicon narratives intensify.
• Buy NVDA calls or call spreads into the next guidance event, 2-6 weeks: the trade is for a positive catalyst from any incremental 2027 commentary; defined downside if the market stays focused on near-term multiple compression.
• Avoid chasing the strongest recent AI gainers at elevated multiples; prefer scaling into names with visible backlog and pricing power on any consolidation, since the next leg should be led by forward guidance, not last quarter's beat.